Neonatal hyperoxia promotes asthma-like features through IL-33–dependent ILC2 responses

Journal of Allergy and Clinical Immunology

Volumn 142, Issue 4, 2018, Pages 1100-1112

  Cheon, In Su ^a,b   Son, Young Min ^a,b   Jiang, Li ^a,b   Goplen, Nicholas P ^b   Kaplan, Mark H ^a   Limper, Andrew H ^b   Kita, Hirohito ^c   Paczesny, Sophie ^a   Prakash, Y S ^b,c   Tepper, Robert ^a   Ahlfeld, Shawn K ^a,d   Sun, Jie ^a,b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

asthma; IL 33; ILC2s; Neonatal hyperoxia; oxidative stress

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 5; REACTIVE OXYGEN METABOLITE; THYMIC STROMAL LYMPHOPOIETIN; IL33 PROTEIN, HUMAN;

ADULT; AIRWAY CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; CHRONIC LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HOUSE DUST; HYPEROXIA-INDUCED LUNG INJURY; LUNG HOMOGENATE; LUNG LAVAGE; LYMPHOID CELL; MALE; MOUSE; NEWBORN; NEWBORN DISEASE; NONHUMAN; OXIDATIVE STRESS; OXYGEN SUPPLY; PREMATURITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE CELL ANALYSIS; TH AND GROUP INNATE LYMPHOID CELL; TREATMENT RESPONSE; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; EPITHELIUM CELL; HUMAN; HYPEROXIA; IMMUNOLOGY; INFANT; KNOCKOUT MOUSE; LYMPHOCYTE; METABOLISM; PRESCHOOL CHILD;

ANIMALS; ANIMALS, NEWBORN; ASTHMA; CELL LINE; CHILD, PRESCHOOL; EPITHELIAL CELLS; FEMALE; HUMANS; HYPEROXIA; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKIN-33; LYMPHOCYTES; MICE, INBRED C57BL; MICE, KNOCKOUT; REACTIVE OXYGEN SPECIES;

EID: 85040597099     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.11.025     Document Type: Article

References (76)

1. Rubens, C.E., Sadovsky, Y., Muglia, L., Gravett, M.G., Lackritz, E., Gravett, C., Prevention of preterm birth: harnessing science to address the global epidemic. Sci Transl Med, 6, 2014, 262sr5.
2. Jensen, E.A., Schmidt, B., Epidemiology of bronchopulmonary dysplasia: birth defects research. Part A Clin Mol Teratol 100 (2014), 145–157.
3. Halterman, J.S., Lynch, K.A., Conn, K.M., Hernandez, T.E., Perry, T.T., Stevens, T.P., Environmental exposures and respiratory morbidity among very low birth weight infants at 1 year of life. Arch Dis Childhood 94 (2009), 28–32.
4. Been, J.V., Lugtenberg, M.J., Smets, E., van Schayck, C.P., Kramer, B.W., Mommers, M., et al. Preterm birth and childhood wheezing disorders: a systematic review and meta-analysis. PLoS Med, 11, 2014, e1001596.
5. Vogel, E.R., Britt, R.D. Jr., Trinidad, M.C., Faksh, A., Martin, R.J., MacFarlane, P.M., et al. Perinatal oxygen in the developing lung. Can J Physiol Pharmacol 93 (2015), 119–127.
6. Cazzato, S., Ridolfi, L., Bernardi, F., Faldella, G., Bertelli, L., Lung function outcome at school age in very low birth weight children. Pediatr Pulmonol 48 (2013), 830–837.
7. Stevens, T.P., Dylag, A., Panthagani, I., Pryhuber, G., Halterman, J., Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasia. Pediatr Pulmonol 45 (2010), 371–379.
8. Laughon, M.M., Langer, J.C., Bose, C.L., Smith, P.B., Ambalavanan, N., Kennedy, K.A., et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med 183 (2011), 1715–1722.
9. Rieger-Fackeldey, E., Park, M.S., Schanbacher, B.L., Joshi, M.S., Chicoine, L.G., Nelin, L.D., et al. Lung development alterations in newborn mice after recovery from exposure to sublethal hyperoxia. Am J Pathol 184 (2014), 1010–1016.
10. Dauger, S., Ferkdadji, L., Saumon, G., Vardon, G., Peuchmaur, M., Gaultier, C., et al. Neonatal exposure to 65% oxygen durably impairs lung architecture and breathing pattern in adult mice. Chest 123 (2003), 530–538.
11. Ahlfeld, S.K., Gao, Y., Conway, S.J., Tepper, R.S., Relationship of structural to functional impairment during alveolar-capillary membrane development. Am J Pathol 185 (2015), 913–919.
12. Liao, J., Kapadia, V.S., Brown, L.S., Cheong, N., Longoria, C., Mija, D., et al. The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia. Nat Commun, 6, 2015, 8977.
13. O'Reilly, M.A., Marr, S.H., Yee, M., McGrath-Morrow, S.A., Lawrence, B.P., Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus. Am J Respir Crit Care Med 177 (2008), 1103–1110.
14. Yee, M., Chess, P.R., McGrath-Morrow, S.A., Wang, Z., Gelein, R., Zhou, R., et al. Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity. Am J Physiol Lung Cell Mol Physiol 297 (2009), L641–L649.
15. Regal, J.F., Lawrence, B.P., Johnson, A.C., Lojovich, S.J., O'Reilly, M.A., Neonatal oxygen exposure alters airway hyper-responsiveness but not the response to allergen challenge in adult mice. Pediatr Allergy Immunol 25 (2014), 180–186.
16. Kumar, V.H., Lakshminrusimha, S., Kishkurno, S., Paturi, B.S., Gugino, S.F., Nielsen, L., et al. Neonatal hyperoxia increases airway reactivity and inflammation in adult mice. Pediatr Pulmonol 51 (2016), 1131–1141.
17. Gasteiger, G., Rudensky, A.Y., Interactions between innate and adaptive lymphocytes. Nat Rev Immunol 14 (2014), 631–639.
18. Artis, D., Spits, H., The biology of innate lymphoid cells. Nature 517 (2015), 293–301.
19. Neill, D.R., Wong, S.H., Bellosi, A., Flynn, R.J., Daly, M., Langford, T.K., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464 (2010), 1367–1370.
20. Martinez-Gonzalez, I., Steer, C.A., Takei, F., Lung ILC2s link innate and adaptive responses in allergic inflammation. Trends Immunol 36 (2015), 189–195.
21. Stier, M.T., Bloodworth, M.H., Toki, S., Newcomb, D.C., Goleniewska, K., Boyd, K.L., et al. Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin. J Allergy Clin Immunol 138 (2016), 814–824.e11.
22. Klein Wolterink, R.G., Kleinjan, A., van Nimwegen, M., Bergen, I., de Bruijn, M., Levani, Y., et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 42 (2012), 1106–1116.
23. Smith, S.G., Chen, R., Kjarsgaard, M., Huang, C., Oliveria, J.P., O'Byrne, P.M., et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol 137 (2016), 75–86.e8.
24. de Kleer, I.M., Kool, M., de Bruijn, M.J., Willart, M., van Moorleghem, J., Schuijs, M.J., et al. Perinatal activation of the interleukin-33 pathway promotes type 2 immunity in the developing lung. Immunity 45 (2016), 1285–1298.
25. Steer, C.A., Martinez-Gonzalez, I., Ghaedi, M., Allinger, P., Matha, L., Takei, F., Group 2 innate lymphoid cell activation in the neonatal lung drives type 2 immunity and allergen sensitization. J Allergy Clin Immunol 140 (2017), 593–595.e3.
26. Halim, T.Y., Steer, C.A., Matha, L., Gold, M.J., Martinez-Gonzalez, I., McNagny, K.M., et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40 (2014), 425–435.
27. Uchida, M., Anderson, E.L., Squillace, D.L., Patil, N., Maniak, P.J., Iijima, K., et al. Oxidative stress serves as a key checkpoint for IL-33 release by airway epithelium. Allergy 72 (2017), 1521–1531.
28. Domm, W., Misra, R.S., O'Reilly, M.A., Affect of early life oxygen exposure on proper lung development and response to respiratory viral infections. Front Med, 2, 2015, 55.
29. Cox, A.M., Gao, Y., Perl, A.T., Tepper, R.S., Ahlfeld, S.K., Cumulative effects of neonatal hyperoxia on murine alveolar structure and function. Pediatr Pulmonol 52 (2017), 616–624.
30. Goncalves, C., Wandalsen, G., Lanza, F., Goulart, A.L., Sole, D., Dos Santos, A., Repercussions of preterm birth on symptoms of asthma, allergic diseases and pulmonary function, 6-14 years later. Allergol Immunopathol (Madr) 44 (2016), 489–496.
31. Tashiro, H., Takahashi, K., Hayashi, S., Kato, G., Kurata, K., Kimura, S., et al. Interleukin-33 from monocytes recruited to the lung contributes to house dust mite-induced airway inflammation in a mouse model. PloS One, 11, 2016, e0157571.
32. Lei, Y., Boinapally, V., Zoltowska, A., Adner, M., Hellman, L., Nilsson, G., Vaccination against IL-33 inhibits airway hyperresponsiveness and inflammation in a house dust mite model of asthma. PloS One, 10, 2015, e0133774.
33. Bouch, S., O'Reilly, M., Harding, R., Sozo, F., Neonatal exposure to mild hyperoxia causes persistent increases in oxidative stress and immune cells in the lungs of mice without altering lung structure. Am J Physiol Lung Cell Mol Physiol 309 (2015), L488–L496.
34. Nguyen, T., Nioi, P., Pickett, C.B., The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284 (2009), 13291–13295.
35. Espinosa-Diez, C., Miguel, V., Mennerich, D., Kietzmann, T., Sanchez-Perez, P., Cadenas, S., et al. Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol 6 (2015), 183–197.
36. Tanito, M., Masutani, H., Kim, Y.C., Nishikawa, M., Ohira, A., Yodoi, J., Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Investig Ophthalmol Vis Sci 46 (2005), 979–987.
37. McGrath-Morrow, S.A., Lauer, T., Collaco, J.M., Lopez, A., Malhotra, D., Alekseyev, Y.O., et al. Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status. Cytokine 65 (2014), 4–9.
38. Noval Rivas, M., Burton, O.T., Oettgen, H.C., Chatila, T., IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function. J Allergy Clin Immunol 138 (2016), 801–811.e9.
39. Giannandrea, M., Yee, M., O'Reilly, M.A., Lawrence, B.P., Memory CD8+ T cells are sufficient to alleviate impaired host resistance to influenza A virus infection caused by neonatal oxygen supplementation. Clin Vaccine Immunol 19 (2012), 1432–1441.
40. Fawke, J., Lum, S., Kirkby, J., Hennessy, E., Marlow, N., Rowell, V., et al. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med 182 (2010), 237–245.
41. Jaakkola, J.J., Ahmed, P., Ieromnimon, A., Goepfert, P., Laiou, E., Quansah, R., et al. Preterm delivery and asthma: a systematic review and meta-analysis. J Allergy Clin Immunol 118 (2006), 823–830.
42. O'Reilly, M., Sozo, F., Harding, R., Impact of preterm birth and bronchopulmonary dysplasia on the developing lung: long-term consequences for respiratory health. Clin Exp Pharmacol Physiol 40 (2013), 765–773.
43. Ahlfeld, S.K., Conway, S.J., Assessment of inhibited alveolar-capillary membrane structural development and function in bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 100 (2014), 168–179.
44. Wang, H., Jafri, A., Martin, R.J., Nnanabu, J., Farver, C., Prakash, Y.S., et al. Severity of neonatal hyperoxia determines structural and functional changes in developing mouse airway. Am J Physiol Lung Cell Mol Physiol 307 (2014), L295–301.
45. Vollsaeter, M., Roksund, O.D., Eide, G.E., Markestad, T., Halvorsen, T., Lung function after preterm birth: development from mid-childhood to adulthood. Thorax 68 (2013), 767–776.
46. Gibson, A.M., Doyle, L.W., Respiratory outcomes for the tiniest or most immature infants. Semin Fetal Neonat Med 19 (2014), 105–111.
47. Islam, J.Y., Keller, R.L., Aschner, J.L., Hartert, T.V., Moore, P.E., Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia. Am J Respir Crit Care Med 192 (2015), 134–156.
48. Lewis, D.B., Gern, J.E., Hill, H.R., Friedlander, S.L., La Pine, T.R., Lemanske, R.F. Jr., et al. Newborn immunology: relevance to the clinician. Curr Probl Pediatr Adolesc Health Care 36 (2006), 189–204.
49. Hong, J.Y., Bentley, J.K., Chung, Y., Lei, J., Steenrod, J.M., Chen, Q., et al. Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells. J Allergy Clin Immunol 134 (2014), 429–439.
50. Saravia, J., You, D., Shrestha, B., Jaligama, S., Siefker, D., Lee, G.I., et al. Respiratory syncytial virus disease is mediated by age-variable IL-33. PLoS Pathog, 11, 2015, e1005217.
51. Halvorsen, T., Skadberg, B.T., Eide, G.E., Roksund, O., Aksnes, L., Oymar, K., Characteristics of asthma and airway hyper-responsiveness after premature birth. Pediatr Allergy Immunol 16 (2005), 487–494.
52. Gold, M.J., Antignano, F., Halim, T.Y., Hirota, J.A., Blanchet, M.R., Zaph, C., et al. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J Allergy Clin Immunol 133 (2014), 1142–1148.
53. Halim, T.Y., Hwang, Y.Y., Scanlon, S.T., Zaghouani, H., Garbi, N., Fallon, P.G., et al. Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol 17 (2016), 57–64.
54. Martinez-Gonzalez, I., Matha, L., Steer, C.A., Ghaedi, M., Poon, G.F., Takei, F., Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation. Immunity 45 (2016), 198–208.
55. Divekar, R., Kita, H., Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr Opin Allergy Clin Immunol 15 (2015), 98–103.
56. Kumar, R.K., Foster, P.S., Rosenberg, H.F., Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations. J Leukocyte Biol 96 (2014), 391–396.
57. Barlow, J.L., Peel, S., Fox, J., Panova, V., Hardman, C.S., Camelo, A., et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 132 (2013), 933–941.
58. Monticelli, L.A., Buck, M.D., Flamar, A.L., Saenz, S.A., Tait Wojno, E.D., Yudanin, N.A., et al. Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat Immunol 17 (2016), 656–665.
59. Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463 (2010), 540–544.
60. Johnston, L.K., Hsu, C.L., Krier-Burris, R.A., Chhiba, K.D., Chien, K.B., McKenzie, A., et al. IL-33 precedes IL-5 in regulating eosinophil commitment and is required for eosinophil homeostasis. J Immunol 197 (2016), 3445–3453.
61. Datta, A., Kim, G.A., Taylor, J.M., Gugino, S.F., Farrow, K.N., Schumacker, P.T., et al. Mouse lung development and NOX1 induction during hyperoxia are developmentally regulated and mitochondrial ROS dependent. Am J Physiol Lung Cell Mol Physiol 309 (2015), L369–L377.
62. Ni, J., Lin, Y.G., Wu, L., Huang, W., Wei, J.F., Jiang, X.Q., Protective effect of activated Nrf2 against hyperoxia-induced lung injury in neonatal rats [in Chinese]. Sichuan Da Xue Xue Bao Yi Xue Ban 46 (2015), 399–402.
63. Poggi, C., Dani, C., Antioxidant strategies and respiratory disease of the preterm newborn: an update. Oxid Med Cell Longev, 2014, 2014, 721043.
64. Asikainen, T.M., White, C.W., Antioxidant defenses in the preterm lung: role for hypoxia-inducible factors in BPD?. Toxicol Appl Pharmacol 203 (2005), 177–188.
65. Rangasamy, T., Guo, J., Mitzner, W.A., Roman, J., Singh, A., Fryer, A.D., et al. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202 (2005), 47–59.
66. Gluck, J., Rymarczyk, B., Kasprzak, M., Rogala, B., Increased levels of interleukin-33 and thymic stromal lymphopoietin in exhaled breath condensate in chronic bronchial asthma. Int Arch Allergy Immunol 169 (2016), 51–56.
67. Guo, Z., Wu, J., Zhao, J., Liu, F., Chen, Y., Bi, L., et al. IL-33 promotes airway remodeling and is a marker of asthma disease severity. J Asthma 51 (2014), 863–869.
68. Cohen, E.S., Scott, I.C., Majithiya, J.B., Rapley, L., Kemp, B.P., England, E., et al. Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nat Commun, 6, 2015, 8327.
69. Jacob, S.V., Coates, A.L., Lands, L.C., MacNeish, C.F., Riley, S.P., Hornby, L., et al. Long-term pulmonary sequelae of severe bronchopulmonary dysplasia. J Pediatr 133 (1998), 193–200.
70. Doyle, L.W., Carse, E., Adams, A.M., Ranganathan, S., Opie, G., Cheong, J.L.Y., et al. Ventilation in extremely preterm infants and respiratory function at 8 years. N Engl J Med 377 (2017), 329–337.
71. Keller, R.L., Feng, R., DeMauro, S.B., Ferkol, T., Hardie, W., Rogers, E.E., et al. Bronchopulmonary dysplasia and perinatal characteristics predict 1-year respiratory outcomes in newborns born at extremely low gestational age: a prospective cohort study. J Pediatr 187 (2017), 89–97.e3.
72. Ronkainen, E., Dunder, T., Peltoniemi, O., Kaukola, T., Marttila, R., Hallman, M., New BPD predicts lung function at school age: follow-up study and meta-analysis. Pediatr Pulmonol 50 (2015), 1090–1098.
73. Mourani, P.M., Sontag, M.K., Younoszai, A., Miller, J.I., Kinsella, J.P., Baker, C.D., et al. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med 191 (2015), 87–95.
74. Nyp, M., Sandritter, T., Poppinga, N., Simon, C., Truog, W.E., Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?. J Perinatol 32 (2012), 64–69.
75. Bhat, R., Salas, A.A., Foster, C., Carlo, W.A., Ambalavanan, N., Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 129 (2012), e682–e689.
76. Laughon, M., Allred, E.N., Bose, C., O'Shea, T.M., Van Marter, L.J., Ehrenkranz, R.A., et al. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics 123 (2009), 1124–1131.